Stock futures were little changed Tuesday, a day after major indexes plunged on worries about AI disruption and uncertainty over the state of President Donald Trump's tariffs.
Eli Lilly (LLY) stock falls as rival Novo Nordisk (NVO) plans to cut Wegovy, Ozempic & Rybelsus U.S. list prices from Jan 1, ...
11hon MSN
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results